Drug: infliximab, recombinant Quarter: 2016Q3
Total Records: 276 Number of Pages: 14
| DRUGNAME | PT | EventCount |
|---|---|---|
| INFLIXIMAB, RECOMBINANT | Therapeutic response unexpected | 2 |
| INFLIXIMAB, RECOMBINANT | Tongue cancer recurrent | 2 |
| INFLIXIMAB, RECOMBINANT | Urinary tract infection | 2 |
| INFLIXIMAB, RECOMBINANT | Varicella | 2 |
| INFLIXIMAB, RECOMBINANT | Vitreous haemorrhage | 2 |
| INFLIXIMAB, RECOMBINANT | Yellow fever | 2 |
| INFLIXIMAB, RECOMBINANT | Abdominal infection | 1 |
| INFLIXIMAB, RECOMBINANT | Abortion induced | 1 |
| INFLIXIMAB, RECOMBINANT | Abortion spontaneous | 1 |
| INFLIXIMAB, RECOMBINANT | Acute myocardial infarction | 1 |
| INFLIXIMAB, RECOMBINANT | Acute respiratory distress syndrome | 1 |
| INFLIXIMAB, RECOMBINANT | Alopecia | 1 |
| INFLIXIMAB, RECOMBINANT | Anal fistula | 1 |
| INFLIXIMAB, RECOMBINANT | Anaphylactic shock | 1 |
| INFLIXIMAB, RECOMBINANT | Anastomotic leak | 1 |
| INFLIXIMAB, RECOMBINANT | Anxiety disorder | 1 |
| INFLIXIMAB, RECOMBINANT | Arthritis bacterial | 1 |
| INFLIXIMAB, RECOMBINANT | Arthropathy | 1 |
| INFLIXIMAB, RECOMBINANT | Aspergillus infection | 1 |
| INFLIXIMAB, RECOMBINANT | Asthma | 1 |
Total Records: 276 Number of Pages: 14